Onco-Innovations Ltd. (ONNVF) Stock Price & Analysis
ONNVF Stock Chart & Stats
- Day’s Range
- $0.15 - $0.18
- 52-Week Range
- $0.15 - $1.19
- Previous Close
- $0.19
- Volume
- N/A
- Average Volume (3M)
- 967
- Market Cap
- $72.82M
- Enterprise Value
- $88.25M
- Total Cash (Recent Filing)
- $1.41M
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- ―
- Beta
- 0.08
- Next Earnings
- Dec 23, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Onco-Innovations Ltd. News
Onco-Innovations Sets Up Australian Subsidiary and Taps New Marketing Partner Ahead of Phase I Trials
Onco-Innovations Ltd. ( ($TSE:ONCO) ) has issued an announcement. Onco-Innovations has executed an engagement agreement with RDI Partners and created a wholly owned Australian subsidiary, Onco-Innovations AU Pty. Ltd., to
ONNVF FAQ
What was Onco-Innovations Ltd.’s price range in the past 12 months?
What is Onco-Innovations Ltd.’s market cap?
When is Onco-Innovations Ltd.’s upcoming earnings report date?
How were Onco-Innovations Ltd.’s earnings last quarter?
Is Onco-Innovations Ltd. overvalued?
Does Onco-Innovations Ltd. pay dividends?
What is Onco-Innovations Ltd.’s EPS estimate?
How many shares outstanding does Onco-Innovations Ltd. have?
What happened to Onco-Innovations Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Onco-Innovations Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Onco-Innovations Ltd. Stock Smart Score
Company Description
Onco-Innovations Ltd.
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company's lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Thomas O'Shaughnessy
- Employees
- 1
- Website
- oncoinnovations.com
- Address
- 7th Street SW, Calgary, AB, T2R 1M1, CA
Onco-Innovations Ltd. (ONNVF) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 3 | 15 |
| Technical Analysis | 3 | 3 | 3 |
| Moving Averages | 0 | 0 | 12 |








